Cooley Godward Kronish
3175 Hanover Street
Palo Alto, CA 94304
03/12/2009
8:00 AM - 10:00 AM
Patent and non-patent periods of market exclusivity are important drivers of product planning and lifecycle management. Drug developers and their investors need to understand the mechanics and opportunities of Orange Book listings in order to anticipate generic substitution and competition issues as well as to plan their exclusivity strategies.
Come hear a panel that includes company representatives as well as patent and FDA counsel to keep up to date with Orange Book issues. Discuss the latest in patent listing and enforcement strategies. Learn about the full range of non-patent exclusivities available for FDA approval. Bring your questions and chart a path to protecting and optimizing the value of your pharmaceutical assets.
WHO SHOULD ATTEND. Investors, legal counsel, regulatory, and business development professionals who need to understand the competitive landscape of pharmaceuticals afforded through patent and market exclusivities derived from FDA and the Orange Book.
SPEAKERS
RSVP REQUIRED. Please reply by March 5. There is no charge to attend this event. Questions? Send an email to Heather Slavey.
MCLE CREDIT. Cooley Godward Kronish LLP certifies that this activity has been approved for MCLE credit by the State Bar of California in the amount of 1.5 hours. Cooley Godward Kronish LLP is a MCLE approved activity provider.